ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

KZIA Kazia Therapeutics Ltd

0.31
-0.0037 (-1.18%)
Pre Market
Last Updated: 09:04:10
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Kazia Therapeutics Ltd KZIA NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.0037 -1.18% 0.31 09:04:10
Open Price Low Price High Price Close Price Prev Close
0.3137
more quote information »

Recent News

Date Time Source Heading
3/27/202410:52IHNWFeaturedPOET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks
3/21/202408:52PRNUSKazia Therapeutics licenses paxalisib to Sovargen for..
3/13/202408:00PRNUSKazia announces presentation of new data at AACR Annual..
2/21/202416:19EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2/21/202409:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/21/202407:30PRNUSKazia Therapeutics Reports Early Conclusion of Clinical..
2/14/202415:41EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/12/202418:35EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/06/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
2/05/202416:19EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
1/18/202416:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/18/202407:30PRNUSKAZIA CONTINUES BOARD RENEWAL WITH TWO NEW APPOINTMENTS
1/12/202416:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/15/202317:26EDGAR2Form F-3 - Registration statement by foreign private issuers
12/06/202308:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/05/202318:02PRNUSKazia Therapeutics Announces Closing of $2 Million..
12/04/202316:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/01/202308:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/01/202308:00PRNUSKazia Therapeutics Announces $2 Million Registered Direct..
11/29/202316:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/29/202316:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/29/202307:01PRNUSKAZIA ANNOUNCES NON-BINDING LETTER OF INTENT FOR THE..
11/21/202307:30PRNUSKAZIA PROVIDES OVERVIEW OF PAXALISIB RELATED PRESENTATIONS..
11/20/202316:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/20/202316:30PRNUSKAZIA ANNOUNCES RECEIPT OF NASDAQ MINIMUM BID NOTIFICATION
11/15/202309:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/15/202308:30PRNUSKAZIA ANNOUNCES THE RELEASE OF PNOC022 CLINICAL STUDY..
11/10/202307:01PRNUSKAZIA ANNOUNCES PUBLICATION IN MOLECULAR CANCER THERAPEUTICS..
11/01/202316:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/01/202307:01PRNUSKAZIA THERAPEUTICS PROVIDES PRELIMINARY UPDATE FROM ONGOING..
10/26/202307:56EDGAR2Form 20-F - Annual and transition report of foreign private..
10/23/202308:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/23/202307:01PRNUSKAZIA THERAPEUTICS ANNOUNCES CLINICAL DATA AT ESMO 2023 FROM..
10/13/202316:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/11/202307:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/11/202307:01PRNUSKazia announces voluntary delisting from ASX
10/10/202315:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/06/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/05/202307:01PRNUSKAZIA THERAPEUTICS ANNOUNCES PRESENTATIONS AT UPCOMING..
9/29/202307:01PRNUSKAZIA THERAPEUTICS ANNOUNCES ACCEPTANCE OF LATE-BREAKING..
9/29/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/05/202307:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/11/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/06/202316:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/06/202307:00PRNUSKAZIA'S PAXALISIB RECEIVES FAST TRACK DESIGNATION FROM FDA..
6/08/202307:00PRNUSKAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO..
5/25/202307:01PRNUSKAZIA CEO, DR. JOHN FRIEND TO PARTICIPATE IN WHITE HOUSE..
4/14/202307:01PRNUSKAZIA REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE..
4/04/202307:00PRNUSKAZIA PRESENTS NEW DATA FOR PAXALISIB AND EVT801 AT AACR..

Your Recent History

Delayed Upgrade Clock